Viralox, UPC 8 63784 00015 0. Immune Balancing Ploypeptide Oral Spray. 5.0 fl. oz. (150 ml) Oral Spray.

Recall Insight

This FDA Food action (record #F-1479-2019) was formally reported on June 26, 2019, with the manufacturer initiating the action on May 15, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Aps BioGroup, Inc is listed as the recalling firm, operating out of Phoenix, AZ. Federal records indicate 7,132 Total Units units are affected.

The documented reason for this recall is: The recall is being conducted as a result of elevated APC levels. Through additional testing, it was determined that the organism is Stenotrophomonas maltophilia. Distribution data in the federal record shows the product reached: Nationwide and Switzerland. No military/govt/VA consignees.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC and NHTSA going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Food. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 7 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.